Buy an EMI or apply fresh: an honest decision framework

A fresh EU EMI authorisation runs nine to twelve months in most member states. That number surprises founders who have read Lithuania's statutory three-month assessment period - but the statute counts from a complete application, and the difference is everything that happens before completeness: pre-application engagement, completeness loops and successive rounds of regulator information requests. We have written up where those months actually go.

The buy route replaces that with a prior qualifying-holding assessment: the regulator vets you, the buyer, before you may acquire control. The window runs up to 60 working days - but the clock stops every time the regulator issues an information request, and it only restarts when you answer in full.

That stopping clock is the part sellers rarely dwell on. Market commentary is consistent that when the buyer file is weak - an ownership chain that takes three diagrams to explain, source of funds that needs a second pass - real approval time on EU and UK EMI acquisitions can approach fresh-authorisation territory. The speed advantage belongs to prepared buyers, not to the buy route as such. Our guide to the change-of-control process covers what a strong buyer file looks like in practice.

An EMI authorisation is not a generic e-money badge. It is a specific permission set, granted against a specific programme of operations, and when you buy the company you inherit that scope exactly as it stands. Buying wins on this axis only when the authorised scope already matches your model.

If your model depends on a permission the target does not hold, the acquisition does not remove the regulatory work - it defers it. Extending scope after closing is a further application, assessed on its own merits, on a timeline that varies by member state. A fast acquisition followed by a slow scope extension is not a fast route to market; it is a fresh application with a premium attached. Applying fresh, by contrast, scopes the licence to your exact model from the first drafting session.

The practical check is simple and worth doing before any pricing conversation: write down the permissions your model needs in its first two years, then read the target's authorisation against that list line by line. Anything on your list that is missing from the licence is post-closing regulatory work you are buying along with the company - and it belongs in the cost comparison, not in a footnote.

A clean, operating entity is the genuine asset in this trade. Beyond the authorisation itself, you are paying for a company whose file a regulator, a bank and an investor can read at face value - live operations, an unbroken record, nothing that needs a covering explanation.

The inverse transfers just as completely. Legacy findings and dormant periods do not stay with the seller; they become part of your story on day one, and banks and investors read the entity's file, not your intentions for it. If clean history matters to the people funding and banking your business, a compromised target is more expensive than its price suggests.

Banking survival is the axis buyers most often skip. Accounts and safeguarding arrangements are relationships with the entity as it was - and a change of control gives every counterparty a reason to re-run its own review. Some banking will not survive the transfer. A target that arrives licensed but effectively unbanked has lost most of the speed argument that justified the purchase.

Acquisition pricing carries a seller premium, and it is discussed publicly only as ranges - pricing is specific to the entity, its scope and its condition, which is why we quote on request rather than publish numbers that would mislead in both directions.

The honest comparison is never premium versus application fee. It is total cost to reliable launch. On the buy side: the premium plus the remediation of whatever diligence finds. On the apply side: the build cost plus nine to twelve months of runway before the licence exists - salaries, advisers and infrastructure funded entirely by patience.

Each route hides one line item from the casual comparison. Runway is the quiet cost of applying; remediation is the quiet cost of buying. Put both on the table and the arithmetic often looks different from the pitch - in either direction. A modest premium on a clean, correctly scoped entity can be cheap next to a year of funded waiting; a discounted entity that needs its history explained and its banking rebuilt can be the most expensive licence you ever acquire.

Advisory-market reporting notes active buyer demand for EU EMIs - buyer mandates in the seven-figure range are publicly discussed. The scarcity is real, and scarcity does something predictable to buyers: it makes compromised targets look acceptable.

That pressure is precisely when diligence discipline pays. Applying fresh wins when you need a specific scope, when clean history is strategic to your banks and investors, or when the targets actually on the market carry legacy findings, dormant periods or banking that will not survive the transfer. Walking away from a scarce asset feels like losing; walking into a nine-month remediation feels worse.

We sell licensed companies, so read this as it is intended: the honest test of any listing - including ours - is whether it beats the fresh application on total cost and total time to a reliable launch. Sometimes it does. Sometimes it does not, and the fresh application is the better decision. A seller who cannot have that conversation is telling you something useful.